TPCA-1 is a direct dual inhibitor for both IKKbeta (IKK-2) and STAT3. It inhibits STAT3 phosphorylation, DNA binding, and transactivation in vivo. Synergistic treatment of TPCA-1 with tyrosine kinase inhibitors (TKIs) can potentially be a more effective met
Molecular Weight:
279.29
Form:
Supplied as a Pale Beige Solid
CAS Number:
[507475-17-4]
* VAT and and shipping costs not included. Errors and price changes excepted
